Agile Therapeutics, Inc. Stock Split Ratio
Agile Therapeutics, Inc. had Stock Split Ratio of 2.00% as of 2023-04-10, per its 10-Q filed 2024-08-12.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2024-08-12
- Agile Therapeutics, Inc. stockholders' equity note, stock split, conversion ratio for fiscal 2022 was 2.50%, a 0.00% change from fiscal 2021.
- Agile Therapeutics, Inc. stockholders' equity note, stock split, conversion ratio for fiscal 2021 was 2.50%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|---|
| 2023-04-10 | 2.00% 10-Q · filed 2024-08-12 | ||
| 2022-12-31 | 2.50% 10-K · filed 2023-03-23 | ||
| 2022-04-26 | 2.50% 10-Q · filed 2022-11-07 | ||
| 2021-12-31 | 2.50% 10-K · filed 2023-03-23 | ||
| 2014-05-05 | 140.00% 10-K · filed 2015-03-26 | 140.00% 10-Q · filed 2014-11-13 |